iPSC-Based cell therapy: an important step forward
- PMID: 24319663
- PMCID: PMC3849244
- DOI: 10.1016/j.stemcr.2013.10.002
iPSC-Based cell therapy: an important step forward
Abstract
Morizane et al. (2013) show that donor-matched differentiated derivatives of induced pluripotent stem cells (iPSC) do not cause an immune response after transplantation, whereas transplantation of HLA-mismatched iPSC derivatives to the same site clearly does. The importance of these results is discussed in this commentary as we assess how best to move forward with iPSC-based cell therapy.
Figures
Comment on
-
Direct comparison of autologous and allogeneic transplantation of iPSC-derived neural cells in the brain of a non-human primate.Stem Cell Reports. 2013 Sep 26;1(4):283-92. doi: 10.1016/j.stemcr.2013.08.007. eCollection 2013. Stem Cell Reports. 2013. PMID: 24319664 Free PMC article.
References
-
- Cave, A. (2013). Stem-cell banks enable wealthy to free “back up version” of their adult selves. The Telegraph, September 9, 2013. http://www.telegraph.co.uk/science/science-news/10295085/Stem-cell-banks....
-
- Cyranoski D. Nature. 2012;488:139. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
